Fiscal Period | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|
Period End Date | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
Net Income/ Starting Line | -15.62 | -9.91 | 0.14 | 0.09 |
Depreciation/ Depletion | 1.72 | 0.02 | 0.01 | 0.04 |
Non- Cash Items | 2.16 | 0.04 | 0.00 | 0.00 |
Changesin Working Capital | 1.12 | 5.84 | -0.41 | 0.27 |
Cashfrom Operating Activities | -10.62 | -4.02 | -0.26 | 0.41 |
Capital Expenditures | -22.86 | -1.67 | - | 0.00 |
Other Investing Cash Flow Items Total | -52.13 | -3.27 | 0.47 | -0.23 |
Cashfrom Investing Activities | -74.99 | -4.94 | 0.47 | -0.23 |
Financing Cash Flow Items | -1.24 | 0.00 | 0.00 | - |
Issuance( Retirement)of Stock Net | 79.82 | 21.31 | - | - |
Issuance( Retirement)of Debt Net | -0.93 | 0.00 | - | 0.00 |
Cashfrom Financing Activities | 77.66 | 21.31 | 0.00 | 0.00 |
Net Changein Cash | -7.95 | 12.35 | 0.21 | 0.18 |
Cash Interest Paid | 1.24 | 0.00 | 0.00 | - |
Cash Taxes Paid | 0.00 | - | 0.00 | 0.00 |
Pharmaids Pharmaceuticals Dividend Pharmaids Pharmaceuticals Bonus Pharmaids Pharmaceuticals News Pharmaids Pharmaceuticals AGM Pharmaids Pharmaceuticals Rights Pharmaids Pharmaceuticals Splits Pharmaids Pharmaceuticals Board Meetings Pharmaids Pharmaceuticals Key Metrics Pharmaids Pharmaceuticals Shareholdings Pharmaids Pharmaceuticals Profit Loss Pharmaids Pharmaceuticals Balance Sheet Pharmaids Pharmaceuticals Q1 Results Pharmaids Pharmaceuticals Q2 Results Pharmaids Pharmaceuticals Q3 Results Pharmaids Pharmaceuticals Q4 Results
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks